Eric Britton is a Senior Scientist II at AbbVie, having transitioned to this role in 2024. They previously served as a Senior Scientist at Cerevel Therapeutics from 2023 to 2024, focusing on the development of treatments for neurological disorders. Eric's earlier experience includes roles at Vertex Pharmaceuticals, where they progressed from Research Associate II to Senior Research Associate and Research Scientist 1 between 2021 and 2023. They began their professional journey with a Summer Internship at Unigene Laboratories, Inc. in 2009 and have also held positions as an Associate Scientist at Agilux Laboratories from 2012 to 2014. Eric earned both a Bachelor and Master of Arts in Biology from Clark University between 2006 and 2013.
This person is not in the org chart
This person is not in any teams
This person is not in any offices